A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can ...

Scientists want to know what causes B cells — which direct T cells to attack cancer — to malfunction and how they can be ...

What happens if cancer cells lose both their mitochondrial energy supply and their glycolytic backup system? This question is ...

Hidden cancer reservoir: Researchers found residual glioblastoma cells in the sub-ventricular zone in 65% of patients, which may drive tumor recurrence. Hormone therapy potential: A Cleveland Clinic ...

A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have ...

A CAR-T therapy used to treat cancer managed to reset the immune system and bring three autoimmune diseases into remission in ...

Cancer survival can be analyzed by individual cells instead of whole tumors, revealing which cell populations drive patient outcomes.

Ascites—the buildup of liquid in the belly—may be doing more than causing discomfort. A Duke University School of Medicine ...

After a disappointing phase 1 showing, Janux Therapeutics is kicking one of its bispecific T-cell engagers (TCEs) ...

Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

Circulating tumor cells were first described in 1869 by Thomas Ashworth, an Australian pathologist who observed them in a peripheral blood sample taken from a patient with metastatic cancer. 1 They ...